-
Nov 4, 2024 | 
radcliffecardiology.com | Mirvat Alasnag |Sahil A. Parikh |David Erlinge |Stephan Baldus
Skip to main content Video Published: Views: 18 Likes: 0 Average (ratings) TCT Conference 2024 - Join us for an engaging conversation with TCT Programme Director, Dr Sahil Parikh (Columbia University Irving Medical Center, US), as he delivers a concise and insightful overview of key late-breaking trials from the TCT 24 Conference.
-
Oct 28, 2024 | 
pcronline.com | Mirvat Alasnag |Nicolas Van Mieghem
Reported from TCT 2024 Mirvat Alasnag interviews Nicolas M. Van Mieghem about the results of the TAVR UNLOAD trial he presented at the TCT Conference 2024. TAVR for moderate AS in Heart Failure with reduced Ejection Fraction (HFrEF) patients on GDMT was safe and improved quality of life at one year but didn't affect the primary endpoint at 23 months.
-
Oct 17, 2024 | 
radcliffecardiology.com | Mirvat Alasnag |Nicolas Van Mieghem |Joost Daemen
Published: Views: 355 Likes: 7 Views: 355 Likes: 7 Share: Average (ratings) Overview Keep informed with our video collectionunveiling data fromthe Transcatheter Cardiovascular Therapeutics Conference in Washington. With expert insights on late-breaking trials and critical findings, you won't want to miss our #TCT24 coverage.
-
Oct 16, 2024 | 
radcliffecardiology.com | Mirvat Alasnag |Nicolas Van Mieghem |Joost Daemen
Overview Keep informed with our video collectionunveiling data fromthe Transcatheter Cardiovascular Therapeutics Conference in Washington. With expert insights on late-breaking trials and critical findings, you won't want to miss our #TCT24 coverage. For practice-focused reviews of the most anticipated trials, watch our recurring View From the Thoraxcenter series, hosted byProf Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).
-
Sep 13, 2024 | 
radcliffecardiology.com | Mirvat Alasnag |Nicolas Van Mieghem |Joost Daemen
In this episode of the "Innovations in Cardiology" series, host Dr Dipti Itchhaporia welcomes two leading experts in artificial intelligence in cardiology: Dr David Ouyang from Cedars-Sinai Medical Center in Los Angeles, and Dr Francisco Lopez-Jiminez from the Mayo Clinic in Rochester, MN. Together, they explore the role of artificial intelligence in cardiology, from diagnostics to personalized treatment strategies.
-
Sep 8, 2024 | 
pcronline.com | Mirvat Alasnag
Reported from ESC Congress 2024Mirvat Alasnag provides her take on REC-CAGEFREE I, a multicenter, non-inferiority trial presented at the ESC Congress 2024 in London. BackgroundThere has been growing enthusiasm for drug-coated balloon (DCB) technology in recent years. Evidence has mounted from multiple trials such as the BASKET-SMALL 2, PICCOLETO II, and AGENT IDE trials.
-
Sep 2, 2024 | 
radcliffecardiology.com | Gi-Byoung Nam |Mirvat Alasnag |Rhian M. Touyz |Vijay Kunadian
Video Published: Views: 7 Likes: 0 Average (ratings) ESC Congress 2024 — Dr Rhian Touyz (McGill University Health Center, CA) joins us to discuss key highlights from the ESC 2024 guidelines for the management of elevated blood pressure and hypertension.
-
Sep 2, 2024 | 
radcliffecardiology.com | Harriette Van Spall |Mirvat Alasnag |Stefan James |Stephan Baldus
ESC Congress 2024 — SWEDEGRAFT does not support the routine use of no-touch vein harvest compared to the standard technique. Dr Harriette Van Spall (McMaster University, CA) sits down with principal investigator Prof Stefan James (Uppsala University, SE) to discuss results of the SWEDEGRAFT trial (NCT03501303; Uppsala University).
-
Sep 2, 2024 | 
radcliffecardiology.com | Gi-Byoung Nam |Harriette Van Spall |Mirvat Alasnag |Dirk-Jan Van Ginkel
ESC Congress 2024 — No benefit of continuing oral anticoagulation during TAVI procedure. Investigator, Dr Dirk-Jan van Ginkel (St Antonius Hospital, NL) joins us to discuss the result of the POPular PAUSE TAVI trial (NCT04437303; St Antonius Hospital).
-
Sep 2, 2024 | 
radcliffecardiology.com | Byeong-Keuk Kim |Harriette Van Spall |Mirvat Alasnag |Scott Solomon
ESC Congress 24 – Day 4 of the ESC Congress 2024 was filled with hot line and late-breaking data poised to influence cardiovascular practice. Interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) joined us to review and distil the key messages from the latest data presented at the last of the biggest cardiovascular event of 2024.
